Jean-Luc Girardet

Jean-Luc Girardet joined Mirum in 2022 and serves as senior vice president of technical operations, overseeing chemistry, manufacturing, and controls (CMC) and clinical supply chain. Jean-Luc brings more than 25 years of operational and technical experience in the biotech and pharmaceutical industry.

Prior to joining Mirum, Jean-Luc served as senior vice president of pharmaceutical sciences at Brii Biosciences from inception (2018) to 2022. From 2007 to 2018, he worked at Ardea Biosciences, a member of the AstraZeneca Group, serving in a variety of executive leadership roles including vice president of pharmaceutical and translational sciences, leading the progression of Ardea’s internal discovery programs from concept to clinical development and eventually to approval. He also led the CMC teams through clinical phases, FDA-approval and launch readiness of Zurampic® and Duzallo®. Earlier in his career, Jean-Luc was at Valeant Pharmaceuticals, Ribapharm and ICN Pharmaceuticals.

Jean-Luc completed a Postdoctoral Fellowship at the University of Michigan in Ann Arbor, Michigan, and he received a Ph.D. in Chemistry and a B.S. in Chemistry and Biochemistry from the University of Montpellier II, France. He co-authored more than 45 publications and book chapters and has been issued 35 U.S. patents.